Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01328249
Brief Title: Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer

First Submitted : March 22, 2011
First Submitted that Met QC Criteria : April 1, 2011
First Posted : April 4, 2011 (Estimate)

Results First Submitted : March 2, 2018
Results First Submitted that Met QC Criteria : August 28, 2018
Results First Posted : September 26, 2018

Last Update Submitted that Met QC Criteria : August 9, 2019
Last Update Posted : August 20, 2019